In a report released today, Heiko Ihle from H.C. Wainwright reiterated a Buy rating on Sierra Metals (SMTS – Research Report), with a price target of $1.50. The company’s shares closed last Friday at $0.57.
According to TipRanks, Ihle is an analyst with an average return of -11.4% and a 29.21% success rate. Ihle covers the Basic Materials sector, focusing on stocks such as Golden Minerals Co, Great Panther Silver, and Hecla Mining Company.
Currently, the analyst consensus on Sierra Metals is a Moderate Buy with an average price target of $1.66.
See today’s best-performing stocks on TipRanks >>
Based on Sierra Metals’ latest earnings release for the quarter ending March 31, the company reported a quarterly revenue of $57.24 million and a net profit of $369 thousand. In comparison, last year the company earned a revenue of $69.62 million and had a net profit of $3.08 million
Based on the recent corporate insider activity of 14 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SMTS in relation to earlier this year.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Sierra Metals, Inc. engages in the production, exploration, and development of precious and base metals. It operates through the Peru and Mexico geographical segments. The Peru segment consists of Yauricocha Mine. The Mexico segment conssits of Bolivar and Cusi Mines. The company was founded on April 11, 1996 and is headquartered in Toronto, Canada.
Read More on SMTS:
- embecta Announces Inaugural Quarterly Cash Dividend
- IDEAYA Biosciences, Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update
- Liberty Gold Receives Final US$6 Million Payment for the Sale of Halilağa Copper-Gold Deposit, Turkey
- Perpetua Resources Announces Second Quarter 2022 Highlights
- Analysts Offer Insights on Healthcare Companies: Medios AG (OtherMEDOF) and Treace Medical Concepts (TMCI)
